Synthesis and biological evaluation of O-methyl and O-ethyl NSAID hydroxamic acids

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 5, 2009, Pages 1179-1187

  Rajić, Zrinka ^a   Perković, Ivana ^a   Butula, Ivan ^a   Zorc, Branka ^a   Hadjipavlou Litina, Dimitra ^b   Pontiki, Eleni ^b   Pepeljnjak, Stjepan ^a   Kosalec, Ivan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antimicrobial activity; Antioxidant activity; Inhibition; NSAID hydroxamic acids; Soybean lipoxygenase; Urease

Indexed keywords

DICLOFENAC DERIVATIVE; FENOPROFEN; HYDROXAMIC ACID DERIVATIVE; HYDROXYL GROUP; IBUPROFEN DERIVATIVE; INDOMETACIN DERIVATIVE; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; UREASE;

ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOYBEAN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BACTERIA; HYDROXAMIC ACIDS; LIPID PEROXIDATION; LIPOXYGENASE INHIBITORS; MOLECULAR STRUCTURE; UREASE;

GLYCINE MAX;

EID: 67651193657     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360902779128     Document Type: Article

References (40)

1. Kleemann EA, Engel J, Kutscher B, Reichert D. Pharmaceutical Substances: Syntheses, Patents, Applications. Stuttgart: Thieme, 2001.
2. Muri EMF, Nieto MJ, Sindelar RD, Williamson JS. Hydroxamic acids as pharmacological agents. Curr Med Chem 2002;9:1631-1653
3. Boznar B, Zmitek J, Kocjan D. 2-(4-Isobutylphenyl)propiohydroxamic acid. BE 830,825 1974 [Chem Abstr 1976;85:62817k]
4. EP 0 203 379 A1 1986 [Chem Abstr 1987;106:84185g].
5. Cetenko WA, Connor DT, Flynn DL, Sircar JC (Warner-Lambert Company). Preparation of hydroxyindeneacetamide, and hydroxyindoleacetamide derivatives of selected nonsteroidal antiinflammatory acyl residues having cyclooxygenase, and 5-lipoxygenase inhibition activity. US 4,943,587 1990 [Chem Abstr 1990;112:216688j].
6. Orzalesi G, Selleri R, Caldini O, Volpato I, Innocenti F, Colome J, Sacristan A, Varez G. Ibuproxam and ibuprofen, a pharmacological comparison. Arzneimittelforschung 1977;27:1006-1012
7. Sloan KB, Little R. Mannich-base hydroxamic acid prodrugs for the improved delivery of nonsteroidal antiinflammatory agents and a pharmaceutical composition containing them. EP 39051 A2 1981 [Chem Abstr 1982;96:104087g].
8. Brooks APM, Day RO. Variability in response to NSAIDs. Fact or fiction? N Engl J Med 1988;1716-1725
9. Shanbhag VR, Crider AM, Gohkale R, Harpalani A, Dick RM. Ester and amide prodrugs of ibuprofen and naproxen: synthesis, antiinflammatory activity, and gastrointestinal toxicity. J Pharm Sci 1992;81:149-154
10. Corey EJ, Cashmin JR, Kanther SS, Wright SW. Antioxidant and antiinflammatory activity of aryl-acetic and hydroxamic acids as novel lipoxygenase inhibitors. J Am Chem Soc 1984;106:1503-1505
11. Amtul Z, Rahman AU, Siddiqui RA, Choudhary MI. Chemistry and mechanism of urease inhibition. Curr Med Chem 2002;9:1323-1348
12. Odake S, Morikava T, Tsuchiya M, Imamura L, Kobashi K. Inhibition of Helicobacter pylori urease activity by hydroxamic acid derivatives. Biol Pharm Bull 1994;17:1329-1332
13. Muri EMF, Mishra H, Steinand SM, Williamson JS. Molecular modeling, synthesis and biological evaluation of heterocyclic hydroxamic acids designed as Helicobacter pylori urease inhibitors. Lett Drug Des Disc 2004;1:30-34
14. Garrido G, Gonzalez D, Delporte C, Backhouse N, Quintero G, Nunez- Selles AJ, Morales MA. Analgesic and antiinflammatory effects of Mangifera indica L. extract (Vimang). Phytother Res 2001;15:18-21.
15. Weber V, Rubat C, Duroux E, Lartigue C, Madesclaire M, Coudert P. New 3- and 4-hydroxyfuranones as antioxidants and antiinflammatory agents. Bioorg Med Chem 2005;13:4552-4564
16. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 2nd edn. Oxford: Clarendon, 1989.
17. Orhan H, Sahin G. In vitro effects of NSAIDs and paracetamol on oxidative stress-related parameters of human erythrocytes. Exp Toxicol Pathol 2001;53:133-140
18. Saldan LA, Elias G, Gao MNA. Oxygen radical scavenging activity of phenylbutenones and their correlation with anti-inflammatory activity. Arzneimittelforschung 1990;40:89-91.
19. Kontogiorgis C, Litinas KE, Makri A, Nicolaides DN, Vronteli A, Hadjipavlou-Litina DJ, Pontiki E, Siohou A. Synthesis and biological evaluation of novel angular fused pyrrolocoumarins. J Enzyme Inhib Med Chem 2008;23:43-49
20. Burguete A, Pontiki E, Hadjipavlou-Litina D, Villar R, Vicente E, Solano B, Ancizu S, Pérez-Silanes S, Aldana I, Monge A. Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1- one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogs. Bioorg Med Chem Lett 2007;17:6439-6443
21. Michaelidou A, Hadjipavlou-Litina D, Matsini I, Tsitsogianni E. Heterocyclic aryl(phenyl)acetic acid and aryl acetohydroxamic acids as antiinflammatory-antioxidant agents and inhibitors of lipoxygenase and serine proteases. Med Chem 2007;3:439-445
22. Molvi KI, Mansuri M, Sudarsanam V, Patel, MM, Andrabi SMA, Haque N. Synthesis, anti-inflammatory, analgesic and antioxidant activities of some tetrasubstituted thiophenes. J Enzyme Inhib Med Chem 2008;23:829-838
23. Maharvi GM, Ali S, Riaz N, Afza N, Malik A, Ashraf M, Iqbal L, Lateef M. Mild and efficient synthesis of new tetraketones as lipoxygenase inhibitors and antioxidants. J Enzyme Inhib Med Chem 2008;23:62-69
24. Suzen S, Gurkok G, Coban T. Novel N-acyl dehydroalanine derivatives as antioxidants: studies on rat liver lipid peroxidation levels and DPPH free radical scavenging activity. J Enzyme Inhib Med Chem 2006;21:179-185
25. Gacche N, Dhole NA, Kamble SG, Bandgar BP. In-vitro evaluation of selected chalcones for antioxidant activity. J Enzyme Inhib Med Chem 2007;23:28-31.
26. Kontogiorgis CA, Savvoglou K, Hadjipavlou-Litina DJ. Antiinflammatory and antioxidant evaluation of novel coumarin derivatives. J Enzyme Inhib Med Chem 2006;21:21-29
27. Zorc B, Antolić S, Butula I. Macromolecular prodrugs. I. Synthesis of some non-steroidal anti-inflammatory drug esters. Acta Pharm 1993;43:127-133
28. Zorc B, Butula I. Macromolecular prodrugs. III. Esters of fenoprofen and probenecid. Acta Pharm 1994;44:103-108
29. Rajić Z, Butula I, Zorc B, Kraljević Pavelić S, Hock K, Pavelić K, Naesens L, De Clercq E, Balzarini J, Przyborowska M, Ossowski T, Mintas M. Cytostatic and antiviral activity evaluations of NSAID hydroxamic acids: a direct implication of JNK in ap optosis induction of HeLa cells. Eur J Med Chem 2009 (in press).
30. European Pharmacopoeia, 5th edn. Strasbourg: Council of Europe, 2006.
31. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved Standard, NCCLS document M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
32. Van Slyke DD, Archibald RM. Manometric, titrimetric and colorimetric methods for measurment of urease activity. J Biol Chem 1944;154:623-642
33. Quan HJ, Koyanagi J, Ohmori K, Uesato S, Tsuchido T, Saito S. Preparation of heterospirostanols and their pharmacological activities. Eur J Med Chem 2002;37:659-669
34. Pontiki E, Hadjipavlou-Litina D. Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents. Bioorg Med Chem 2007;15:5819-5827
35. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26:1231-1237
36. Biobyte Corp. C-QSAR Database. Claremont, CA: Biobyte Corp.
37. Taraborewala RB, Kauffman JM. Synthesis and structure-activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridinealkanoic acids and 4-(2-carboxyphenyl)aminobenzenealkanoic acids. J Pharm Sci 1990;79:173-178
38. Pontiki E, Hadjipavlou-Litina D. Quantitative-structure activity relationships on lipoxygenase inhibitors. Internet Electron J Mol Des 2002;1:134-141
39. Pontiki E, Hadjipavlou-Litina D. Review in quantitative structure activity relationships on lipoxygenase inhibitors. Mini Rev Med Chem 2003;3:487-499
40. Pontiki E, Hadjipavlou-Litina D. Quantitative structure activity relationships (QSARs) on lipoxygenase inhibitors. Curr Med Chem Anti- Inflammatory Anti-Allergy Agents 2004;3:139-156